EULAV Asset Management’s ResMed RMD Stock Holding History

EULAV Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,000	Closed	-$933K	–	330
2015 Q1	$933K	Hold	13,000	–	–	0.05%	288
2014 Q4	$729K	Hold	13,000	–	–	0.04%	305
2014 Q3	$641K	Hold	13,000	–	–	0.03%	317
2014 Q2	$658K	Hold	13,000	–	–	0.04%	346
2014 Q1	$581K	Hold	13,000	–	–	0.03%	350
2013 Q4	$612K	Hold	13,000	–	–	0.03%	357
2013 Q3	$687K	Buy	13,000 +4,000	+44%	+$194K	0.04%	355
2013 Q2	$406K	Buy	+9,000	New	+$427K	0.02%	382

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EULAV Asset Management's RMD Position: Q2 2015 in Review

EULAV Asset Management sold out of ResMed (RMD) in Q2 2015, closing a stake of 13,000 shares — an estimated $933K sold.

EULAV Asset Management first reported a position in RMD in Q2 2013 and held it in 8 quarters. The position peaked at $933K in Q1 2015. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

EULAV Asset Management reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
EULAV Asset Management sold 13,000 ResMed shares in Q2 2015, an estimated $933K.
EULAV Asset Management first reported a position in ResMed in Q2 2013 and held it in 8 quarters.
EULAV Asset Management's ResMed position peaked at $933K in Q1 2015.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on EULAV Asset Management's 13F filing for Q2 2015, filed 17 Aug 2015.